Case report: Use of (68)Ga-DOTATATE-PET for treatment guidance in complex meningioma disease

Currently, contrast-enhanced MRI is the method of choice for treatment planning and follow-up in patients with meningioma. However, positron emission tomography (PET) imaging of somatostatin receptor subtype 2 (SSTR2) expression using (68)Ga-DOTATATE may provide a higher sensitivity for meningioma d...

Descripción completa

Detalles Bibliográficos
Autores principales: Meißner, Anna-Katharina, von Spreckelsen, Niklas, Al Shughri, Abdulkader, Brunn, Anna, Fuertjes, Gina, Schlamann, Marc, Schmidt, Matthias, Dietlein, Markus, Rueß, Daniel, Ruge, Maximilian I., Galldiks, Norbert, Goldbrunner, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596965/
https://www.ncbi.nlm.nih.gov/pubmed/36313670
http://dx.doi.org/10.3389/fonc.2022.1017339
Descripción
Sumario:Currently, contrast-enhanced MRI is the method of choice for treatment planning and follow-up in patients with meningioma. However, positron emission tomography (PET) imaging of somatostatin receptor subtype 2 (SSTR2) expression using (68)Ga-DOTATATE may provide a higher sensitivity for meningioma detection, especially in cases with complex anatomy or in the recurrent setting. Here, we report on a patient with a multilocal recurrent atypical meningioma, in which (68)Ga-DOTATATE PET was considerably helpful for treatment guidance and decision-making.

Ejemplares similares